Schizophrenia and Psychosis

Authors propose various pathways to the phenomena of voice-hearing in clinical and nonclinical populations.

A new study examines the effects of CBD as an adjunct therapy to antipsychotic medication for patients diagnosed with schizophrenia.

Review compares the effectiveness of pharmacological and non-pharmacological interventions for improving physical health outcomes in people diagnosed with schizophrenia.

A new study has found that of 10 people who were fully recovered from their first episode of schizophrenia (FES), those not taking antipsychotics did better in terms of cognitive, social, and role functioning—and reached full recovery more quickly.

Individuals diagnosed with a psychotic disorder are 4-6 times more likely than the general population to experience victimization.

An article on contributory injustice describes the clinical and ethical imperative that clinicians listen to service users experiences.

A new study has found that children and adolescents taking a high dose of antipsychotics are almost twice as likely to die of any cause than children on other types of medications.

Researchers reveal the limitations and misleading interpretations of two recent studies that claim to demonstrate that long-term antipsychotic use leads to better outcomes.

Severe infections requiring hospitalizations increased the risk of hospital contacts due to mental disorders by 84% and the risk of psychotropic medication use by 42%.

A new study in JAMA Psychiatry investigates the relationship between trauma and psychotic experiences.

Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.

Researchers explore how family interventions for psychosis might be adapted to China’s emerging integrated mental health care landscape.

A new analysis of antipsychotic treatment of schizophrenia (published in Schizophrenia Bulletin) has found that two-thirds of patients treated this way do not experience symptom remission.

Researchers look at voice hearing experiences shared by nonclinical samples, exploring these experiences in the general population.

A systematic review of the limited research available on the long-term effects of antipsychotics finds fewer symptoms in those off of the drugs.

Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.

When controlling for social and family characteristics, separating children from parents into out-of-home care increases psychiatric issues, prescriptions, and criminal activity.

Researchers examine the relationship between vitamin D and clinical and cognitive symptoms in first-episode psychosis.

Hallucinations and other psychotic symptoms have been reported after methylphenidate (Ritalin) treatment for ADHD.

People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.

Research investigates clinicians’ perspectives on best care practices and the complicated realities of providing care in the face of agency limitations and mechanized interventions.

Researchers investigate the first-person experiences of people who disagreed with their psychiatric diagnosis of psychosis.

Researchers parse out factors within urbanicity that leads to risk for psychotic experiences.

Study finds that reduced cortical thickness and brain surface area associated with 'schizophrenia' may result from antipsychotic drug use.

Coordinated care with employment support and family therapy leads to superior outcomes for those diagnosed with psychotic disorders.